Carter Bruce L A - Net Worth and Insider Trading
Carter Bruce L A Net Worth
The estimated net worth of Carter Bruce L A is at least $1 Million dollars as of 2024-04-25. Carter Bruce L A is the Director of Xencor Inc and owns about 48,578 shares of Xencor Inc (XNCR) stock worth over $923,954. Carter Bruce L A is the Director of Mirati Therapeutics Inc and owns about 6,021 shares of Mirati Therapeutics Inc (MRTX) stock worth over $353,433. Carter Bruce L A is also the Director of Enanta Pharmaceuticals Inc and owns about 0 shares of Enanta Pharmaceuticals Inc (ENTA) stock worth over $0. Besides these, Carter Bruce L A also holds Regulus Therapeutics Inc (RGLS) . Details can be seen in Carter Bruce L A's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Carter Bruce L A has not made any transactions after 2022-08-12 and currently still holds the listed stock(s).
Transaction Summary of Carter Bruce L A
Carter Bruce L A Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Carter Bruce L A owns 6 companies in total, including Mirati Therapeutics Inc (MRTX) , Enanta Pharmaceuticals Inc (ENTA) , and Xencor Inc (XNCR) among others .
Click here to see the complete history of Carter Bruce L A’s form 4 insider trades.
Insider Ownership Summary of Carter Bruce L A
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
MRTX | Mirati Therapeutics Inc | 2022-08-12 | director |
ENTA | Enanta Pharmaceuticals Inc | 2022-03-21 | director |
XNCR | Xencor Inc | 2017-06-14 | director |
RGLS | Regulus Therapeutics Inc | 2015-04-13 | director |
NVLNF | Novelion Therapeutics Inc | 2011-05-26 | director |
ALOR | ALSP Orchid Acquisition Corp I | 2021-11-18 | director |
Carter Bruce L A Latest Holdings Summary
Carter Bruce L A currently owns a total of 4 stocks. Among these stocks, Carter Bruce L A owns 48,578 shares of Xencor Inc (XNCR) as of June 14, 2017, with a value of $923,954 and a weighting of 72.33%. Carter Bruce L A owns 6,021 shares of Mirati Therapeutics Inc (MRTX) as of August 12, 2022, with a value of $353,433 and a weighting of 27.67%. Carter Bruce L A also owns 0 shares of Enanta Pharmaceuticals Inc (ENTA) as of March 21, 2022, with a value of $0 and a weighting of 0%. The other 1 stocks Regulus Therapeutics Inc (RGLS) have a combined weighting of 0% among all his current holdings.
Latest Holdings of Carter Bruce L A
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
XNCR | Xencor Inc | 2017-06-14 | 48,578 | 19.02 | 923,954 |
MRTX | Mirati Therapeutics Inc | 2022-08-12 | 6,021 | 58.70 | 353,433 |
ENTA | Enanta Pharmaceuticals Inc | 2022-03-21 | 0 | 12.92 | 0 |
RGLS | Regulus Therapeutics Inc | 2015-04-13 | 0 | 2.22 | 0 |
Holding Weightings of Carter Bruce L A
Carter Bruce L A Form 4 Trading Tracker
According to the SEC Form 4 filings, Carter Bruce L A has made a total of 0 transactions in Xencor Inc (XNCR) over the past 5 years. The most-recent trade in Xencor Inc is the sale of 20,000 shares on June 14, 2017, which brought Carter Bruce L A around $412,200.
According to the SEC Form 4 filings, Carter Bruce L A has made a total of 9 transactions in Mirati Therapeutics Inc (MRTX) over the past 5 years, including 0 buys and 9 sells. The most-recent trade in Mirati Therapeutics Inc is the sale of 10,000 shares on August 12, 2022, which brought Carter Bruce L A around $854,900.
According to the SEC Form 4 filings, Carter Bruce L A has made a total of 1 transactions in Enanta Pharmaceuticals Inc (ENTA) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Enanta Pharmaceuticals Inc is the sale of 6,000 shares on March 21, 2022, which brought Carter Bruce L A around $406,980.
More details on Carter Bruce L A's insider transactions can be found in the Insider Trading History of Carter Bruce L A table.Insider Trading History of Carter Bruce L A
- 1
Carter Bruce L A Trading Performance
Carter Bruce L A Ownership Network
Ownership Network List of Carter Bruce L A
Ownership Network Relation of Carter Bruce L A
Carter Bruce L A Owned Company Details
What does Mirati Therapeutics Inc do?
Who are the key executives at Mirati Therapeutics Inc?
Carter Bruce L A is the director of Mirati Therapeutics Inc. Other key executives at Mirati Therapeutics Inc include EVP & Chief Commercial Officer Benjamin Hickey , Sr. Vice President & Chief Scie Jamie Christensen , and Interim CFO Aaron Ondrey .
Mirati Therapeutics Inc (MRTX) Insider Trades Summary
Over the past 18 months, Carter Bruce L A made no insider transaction in Mirati Therapeutics Inc (MRTX). Other recent insider transactions involving Mirati Therapeutics Inc (MRTX) include a net sale of 16,852 shares made by Jamie Christensen , a net sale of 12,809 shares made by Benjamin Hickey , and a net sale of 81,996 shares made by Charles M Baum .
In summary, during the past 3 months, insiders sold 0 shares of Mirati Therapeutics Inc (MRTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 126,645 shares of Mirati Therapeutics Inc (MRTX) were sold and 2,528,737 shares were bought by its insiders, resulting in a net purchase of 2,402,092 shares.
Mirati Therapeutics Inc (MRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Mirati Therapeutics Inc Insider Transactions
Carter Bruce L A Mailing Address
Above is the net worth, insider trading, and ownership report for Carter Bruce L A. You might contact Carter Bruce L A via mailing address: C/o Zymogenetics, Inc., 1201 Eastlake Avenue, Seattle Wa 98102.